Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Development and successful clinical application of preimplantation genetic haplotyping for Herlitz junctional epidermolysis bullosa.
[junctional epidermolysis bullosa]
Herlitz
junctional
epidermolysis
bullosa
(
HJEB
)
is
a
severe
,
life-threatening
,
autosomal
recessive
blistering
skin
disease
for
which
no
cure
is
currently
available
.
Prenatal
diagnosis
for
couples
at
risk
is
feasible
through
fetal
skin
biopsy
or
analysis
of
DNA
extracted
from
chorionic
villi
,
but
these
methods
can
be
applied
only
after
pregnancy
has
been
established
.
An
alternative
approach
,
which
involves
the
analysis
of
single
cells
from
embryos
prior
to
establishment
of
pregnancy
,
is
preimplantation
genetic
diagnosis
(
PGD
)
.
Until
now
,
its
clinical
uptake
has
been
hindered
by
lengthy
delays
in
establishing
mutation
-
specific
protocols
,
and
by
the
small
amount
of
template
DNA
that
can
be
obtained
from
a
single
cell
.
A
new
method
that
addresses
these
problems
,
preimplantation
genetic
haplotyping
(
PGH
)
,
relies
on
whole
genome
amplification
followed
by
haplotyping
of
multiple
polymorphic
markers
using
standard
DNA-based
polymerase
chain
reaction
(
PCR
)
assays
.
To
design
and
validate
a
generic
PGH
assay
for
HJEB
and
to
transfer
this
into
clinical
practice
.
We
established
a
multiplex
PCR-based
PGH
assay
involving
16
markers
within
and
flanking
the
LAMB
3
gene
(
the
most
frequently
mutated
gene
in
HJEB
)
.
The
assay
was
then
validated
in
10
families
with
at
least
one
previously
affected
offspring
.
After
licensing
by
the
Human
Fertilisation
and
Embryology
Authority
(
HFEA
)
,
the
new
test
was
used
for
PGD
in
a
couple
at
risk
of
HJEB
.
T
he
chromosome
1
LAMB
3
markers
within
the
assay
were
shown
to
be
of
sufficient
heterogeneity
to
have
widespread
application
for
preimplantation
testing
of
HJEB
.
In
one
couple
that
were
heterozygous
carriers
of
nonsense
mutations
in
LAMB
3
,
we
used
the
new
assay
to
identify
unaffected
embryos
in
a
series
of
PGD
cycles
.
Pregnancy
was
established
in
the
third
PGD
cycle
and
a
healthy
,
unaffected
child
was
born
.
DNA
analysis
of
cord
blood
confirmed
the
predicted
single
-cell
mutation
status
of
wild-
type
LAMB
3
alleles
.
PGH
represents
a
major
step
forward
in
widening
the
scope
and
availability
of
preimplantation
testing
for
serious
mapped
single
-
gene
disorders
.
We
have
established
a
generic
test
that
is
suitable
for
the
majority
of
couples
at
risk
of
HJEB
.
Diseases
Validation
Diseases presenting
"single-cell mutation status"
symptom
junctional epidermolysis bullosa
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom